Výsledky vyhledávání - "Yoshihiko Kamada"

Pilot Study of Irinotecan and S-1 (IRIS) for Advanced and Metastatic Breast Cancer

Autor: Tatsuya Uga, Toshihiro Tanaka, Kyuichirou Miyara, Kazuo Tamura, Maki Tanaka, Shoshu Mitsuyama, Yoshihiko Kamada, Kbc-Sg, Keisei Anan, Hidemi Furusawa, Yoshiaki Sagara, Yuichirou Kai

Publikováno v: Anticancer Research. 40:4779-4785

Background/aim Irinotecan is rarely used on the metastatic breast cancer (MBC) setting. S-1 is an oral mixture of tegafur, gimeracil and oteracil. We conducted this pilot study to assess efficacy and safty of chemotherapy with combined irinotecan and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a61fd55f99c3843ca47027ec2b72f1bc
https://doi.org/10.21873/anticanres.14480

Zobrazit plný text záznamu

Survival of stage 4 primary breast cancer cases after surgery by intrinsic subtype: HER2-positive subtype potentially curable

Autor: Yoshihiko Kamada, Naoko Takigami, Kanou Uehara, Kentaro Tamaki, Nobumitsu Tamaki

Publikováno v: Journal of Clinical Oncology. 40:e13026-e13026

e13026 Background: With the incorporation of anti-HER2 agents in the treatment of HER2 positive primary breast cancer, stage 4 disease of this subtype has become potentially curable. However, the duration of clinical CR that is needed be certain that

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4b62712de2298c8824668d0bbcc81512
https://doi.org/10.1200/jco.2022.40.16_suppl.e13026

Zobrazit plný text záznamu

Breast Cancer, Diabetes Mellitus and Glucagon-Like Peptide-1 Receptor Toward Exploring Their Possible Associations

Autor: Yasuhiro Miki, Ayako Kanai, Nobumitsu Tamaki, Naoko Takigami, Yoshihiko Kamada, Hironobu Sasano, Shigeharu Terukina, Kentaro Tamaki, Erina Iwabuchi, Seiko Tsuchiya, Shimpei Kuniyoshi, Minoru Miyashita, Takanori Ishida, Kano Uehara

Publikováno v: Breast cancer research and treatment. 189(1)

Purpose: Diabetes Mellitus (DM) has been one of the well known risk factors of breast cancer (BC) development and also associated with adverse clinical outcomes of BC patients. Glucagon-like peptide-1 (GLP-1) receptor agonists have been used as antid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::554e97f7f9dc42dab1c9ebb698f629c9
https://pubmed.ncbi.nlm.nih.gov/34606001

Zobrazit plný text záznamu

Abstract P5-13-18: The feasibility of nurse intervention to improve and maintain the BMI of breast cancer survivors over 25 to appropriate levels

Autor: Kanou Uehara, M Arakaki, H Gushikawa, Yoshihiko Kamada, Kentaro Tamaki

Publikováno v: Cancer Research. 77:P5-13

Background: Some studies have shown that women with breast cancer who have a BMI value gain of more than 2.0 kg/m2 after diagnosis have an elevated risk of dying of breast cancer, and likewise breast cancer patients who gained 5 or more kilogramshad

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1a066adef48a32c58c964552e5aaea21
https://doi.org/10.1158/1538-7445.sabcs16-p5-13-18

Zobrazit plný text záznamu

Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancer

Autor: Mikiko Unesoko, Naoki Yoshimi, Kano Uehara, Kentaro Tamaki, Yoshihiko Kamada, Norie Abe, Reika Takamatsu, Nobumitsu Tamaki, Hirofumi Matsumoto, Norihiro Nakada, Tokiwa Motonari, Hisamitsu Zaha, Naoko Takigami

Publikováno v: Virchows Archiv : an international journal of pathology. 476(5)

As visual quantification of the density of tumor-infiltrating lymphocytes (TILs) lacks in precision, digital image analysis (DIA) approach has been applied in order to improve. In several studies, TIL density has been examined on hematoxylin and eosi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5851f686e1d8ddf80d5a5255a070086d
https://pubmed.ncbi.nlm.nih.gov/31873876

Zobrazit plný text záznamu

Abstract P1-10-29: Randomized trial of aromatherapy vs. conventional care for breast cancer patients during perioperative periods

Autor: M Arakaki, Shigeharu Terukina, Yoshihiko Kamada, K Yamashiro, Kentaro Tamaki, Kanou Uehara, Minoru Miyashita, Takanori Ishida, Noriaki Ohuchi, A Komatsu-Fukuyama, Hironobu Sasano, Nobumitsu Tamaki

Publikováno v: Cancer Research. 76:P1-10

PURPOSE: The aromatherapy has been performed as palliative care of the breast cancer patients but no studies have been reported regarding whether the therapy improved QOL of the patients during perioperative periods or not. Therefore, in this study,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ce77a72a26a4c7a56c1cc5b8388cd02f
https://doi.org/10.1158/1538-7445.sabcs15-p1-10-29

Zobrazit plný text záznamu

Comparison of pathological features of estrogen receptor-positive/HER2-negative early breast cancer in the intermediate-risk group of the 21 gene recurrence score (Oncotype Dx) divided into low and high-risk groups by the 95 gene classifier (Curebest 95GC Breast)

Autor: Naoko Takigami, Kanou Uehara, Seiko Tsuchiya, Nobumitsu Tamaki, Yoshihiko Kamada, Kentaro Tamaki

Publikováno v: Journal of Clinical Oncology. 38:e12535-e12535

e12535 Background: Oncotype Dx is becoming the standard assay for chemotherapy decision making for estrogen receptor positive / HER2 negative early breast cancer. Issues concerning the choice of therapy for the intermediate risk patients are currentl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::33ea06ac408096b0babd1ab885d45393
https://doi.org/10.1200/jco.2020.38.15_suppl.e12535

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání